Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with ...

CAMBRIDGE, Mass., April 22, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today ...

Combining pioneering iPSC technology and patented live cell bioimaging, LumiSTAR is opening up exciting new possibilities in the treatment of various diseases and the development of innovative new dru ...

After transplantation into the brain of patients with Parkinson’s disease, allogeneic dopaminergic progenitors derived from induced pluripotent stem cells survived, produced dopamine and did not ...

Two new studies suggest that Parkinson's disease can potentially be treated with stem cells placed in a patient's brain.

Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

On the day of Coontz’s procedure, Gary Steinberg, the chair of neurosurgery, drilled a nickel-size burr hole into Coontz’s skull and injected stem cells around the affected part of her brain.

It is the first trial in the US to study pluripotent stem cell-derived dopaminergic neurons in patients with Parkinson's, according to the company. The first patient in the trial, which will ...